ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2019

Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis.

Richard Phelps et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.